Ventracor Limited (ASX:VCR) Announce Results Of US Feasibility Trial Of The VentraAssist LVAD

Ventracor Limited (ASX:VCR)(US:VTCRY) released the clinical results of the US Feasibility Trial of the VentrAssist(R) Left Ventricular Assist Device (LVAD). The results were presented on Saturday 12 April at the annual meeting of the International Society of Heart and Lung Transplantation (ISHLT) in Boston by Dr. Andrew Boyle, Assistant Professor of Medicine at the University of Minnesota Medical School, in Minneapolis MN.

More: continued here

Filed under: Transplants on April 17th, 2008